Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday. Separately, Piper Sandler downgraded shares of Eagle Pharmaceuticals from a “neutral” rating to an “underweight” rating and reduced their target price for the company from $26.00 […]
Eagle Pharmaceuticals (NASDAQ:EGRX) Releases FY 2023 Earnings Guidance themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Piper Sandler downgraded Eagle Pharmaceuticals from a neutral rating to an underweight rating and decreased their price objective for the […]
Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) was downgraded by research analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research note issued on Wednesday, MarketBeat Ratings reports. They presently have a $17.00 price target on the specialty pharmaceutical company’s stock, down from their prior price target of $26.00. Piper […]
Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) was downgraded by equities research analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. They currently have a $17.00 target price on the specialty pharmaceutical company’s stock, down from their prior target price of […]